Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Revenue Growth (3y) (2012 - 2026)

Analysis

Edwards Lifesciences (EW) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 8.07%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 18.10%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 8.20%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 9.66%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 14.78%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 10.83%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 4.73%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 14.51%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 8.05%
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 5.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.83%
Mar 31, 2026 10.52%
Dec 31, 2025 53.98%
Sep 30, 2025 5.60%
Jun 30, 2025 3.70%
Mar 31, 2025 1.75%
Dec 31, 2024 1.39%
Sep 30, 2024 1.11%
Jun 30, 2024 -0.16%
Mar 31, 2024 3.01%
Dec 31, 2023 2.05%
Sep 30, 2023 2.91%
Jun 30, 2023 11.40%
Mar 31, 2023 2.66%
Dec 31, 2022 -28.46%
Sep 30, 2022 6.43%
Jun 30, 2022 8.12%
Mar 31, 2022 10.54%
Dec 31, 2021 10.79%
Sep 30, 2021 13.06%